agena-bioscience-logo agena-bioscience-logo Close

Phone: (858) 882-2800

Designed for Resilience Against Emerging Mutations

The MassARRAY® SARS-CoV-2 Panel enables high-throughput, low-cost molecular detection with built-in resilience against the emergence of new variants. Available for in vitro diagnostic use under Emergency Use Authorization by the F.D.A. and CE-IVD marked in Europe.

Applications for the MassARRAY® System

PGx Testing Pharmacogenetics
Liquid Biopsy Liquid Biopsy
Tissue Tumor Profiling Tumor Profiling
SARS-CoV-2 Detection SARS-CoV-2
Sample Integrity Sample Integrity
Cystic Fibrosis Testing Hereditary Genetics
Methylation Test Methylation
Chimerism
Blood Group Genotyping Blood Typing
View All Application Areas

Video:

Testing on the MassARRAY System

Discover how labs across the world use our core technology to achieve faster decisions and greater productivity in precision medicine.

The MassARRAY System is helping
genetics labs around the world, with:

  • Minimal Bioinformatics Analysis
  • Maximum Productivity
  • Flexible Biomarker Detection
  • Broad Multiplexing Range
  • Simple Workflow
  • Cost-Effective Testing
Learn More

Upcoming Events

Latest Press

Agena Bioscience announces high-throughput, low-cost panel for molecular detection of SARS-CoV-2, Influenza A, and Influenza B

1 December 2020

Agena Bioscience Granted EUA for High-Throughput, Low-Cost SARS-CoV-2 Panel

28 October 2020

Agena Bioscience Launches High-Throughput, Low-Cost SARS-CoV-2 Detection Panel in Europe with CE-IVD Marking

25 September 2020

Don’t let high cost NGS reagents burden your lab.

The MassARRAY® System Allows for the Lowest Price Per Sample.

Calculate Savings